2 results
Approved WMOPending
This is a clinical performance study of PD-L1 IHC 22C3 pharmDx on non-squamous non-small cell lung cancer specimens. PD-L1 IHC 22C3 pharmDx will be used to select non-squamous NSCLC patients eligible for the TROPION-Lung07…
Approved WMORecruiting
The aim of this study is to determine if the use of Nasal high flow in patients with exacerbation COPD and/of pneumonia gives more comfort and a faster recovery then regular oxygen therapy